Bilthoven and Maastricht, the Netherlands, 6 January 2021 – Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, to
We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug
TargED Biopharmaceuticals, a biotech spin-
“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook
Sirius Medical is proud to announce the first clinical results and global commercial implants of the Sirius Pintuition system.
The first clinical safety and performance study shows that Sirius Pintuition System is safe and performs as intended for breast cance